首页> 外国专利> Use of 4-galactosyl-xylose in humans for in vivo intestinal lactase as noninvasive evaluation test of the deficiency of this enzyme diagnosed.

Use of 4-galactosyl-xylose in humans for in vivo intestinal lactase as noninvasive evaluation test of the deficiency of this enzyme diagnosed.

机译:将4-半乳糖基-木糖用于人体内肠道乳糖酶作为诊断该酶缺乏症的非侵入性评估试验。

摘要

Employment of 4-galactosyl-xylose in humans for in vivo evaluation of intestinal lactase as a noninvasive diagnostic test of the deficiency of this enzyme.; Use in humans based on the use of 4-galactosyl method integrating in this method an alternative to determining technique xylose in urine, consisting of evaluating the concentration of xylose in blood after administration to the patient of 4-galactosyl-xylose, that it is more suitable for use in case of newborns.; Technology for in vivo evaluation of intestinal lactase activity, as non - invasive test for the diagnosis of deficiency of this enzyme, which is based on the direct assessment of the overall activity of the enzyme in the complete individual, not the assessment of consequences of its deficiency, does not require specialized aparataje, it causes no apparent discomfort in patients with lactase deficiency and is highly reliable, thus overcoming the drawbacks of currently used diagnostic tests.
机译:在人类中使用4-半乳糖基-木糖进行肠道乳糖酶的体内评估,作为对该酶缺乏症的非侵入性诊断测试。基于4-半乳糖基方法在人类中的应用,该方法结合了确定尿液中木糖技术的另一种方法,包括评估向患者施用4-半乳糖基-木糖后血液中木糖的浓度,适用于新生儿。用于对肠内乳糖酶活性进行体内评估的技术,作为诊断该酶缺乏症的非侵入性测试,该技术基于直接评估完整个体中该酶的整体活性,无需评估其缺乏的后果,不需要专门的天麻素,它对乳糖酶缺乏症的患者不会造成明显的不适,并且高度可靠,从而克服了目前使用的诊断测试的弊端。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号